Edition:
United States

Tenax Therapeutics Inc (TENX.OQ)

TENX.OQ on NASDAQ Stock Exchange Capital Market

5.50USD
25 Sep 2018
Change (% chg)

-- (--)
Prev Close
$5.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,724
52-wk High
$12.59
52-wk Low
$4.42

Chart for

About

Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely... (more)

Overall

Beta: 1.75
Market Cap(Mil.): $7.78
Shares Outstanding(Mil.): 1.47
Dividend: --
Yield (%): --

Financials

  TENX.OQ Industry Sector
P/E (TTM): -- 109.17 32.55
EPS (TTM): -3.94 -- --
ROI: -64.34 1.47 12.80
ROE: -64.34 0.22 14.92

BRIEF-Tenax Therapeutics Files For Mixed Shelf Of Up To $75 Mln

* TENAX THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $75 MILLION – SEC FILING Source text: (http://bit.ly/2rK4oYR) Further company coverage:

May 15 2018

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF82.84 -0.34
Merck & Co., Inc. (MRK.N) $70.65 -0.13
Roche Holding Ltd. (ROG.S) CHF235.70 -0.45
Roche Holding Ltd. (RO.S) CHF236.60 -0.40
Abbott Laboratories (ABT.N) $72.20 +0.76
Bayer AG (BAYGn.DE) €75.98 +0.38
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €74.74 +0.13
Eli Lilly And Co (LLY.N) $105.70 +0.11
Bristol-Myers Squibb Co (BMY.N) $61.82 +0.23

Earnings vs. Estimates